West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 746,900 | 702,100 | 695,400 | 732,000 | 747,400 |
| Cost of Goods | 482,200 | 472,100 | 465,200 | 453,800 | 459,100 |
| Gross Profit | 264,700 | 230,000 | 230,200 | 278,200 | 288,300 |
| Operating Expenses | 103,600 | 103,900 | 107,600 | 118,100 | 111,100 |
| Operating Income | 161,300 | 126,200 | 122,800 | 160,900 | 177,300 |
| Interest Expense | 700 | 1,500 | 1,600 | 1,200 | 2,900 |
| Other Income | 7,800 | 8,500 | 10,500 | 11,800 | 16,300 |
| Pre-tax Income | 168,400 | 133,200 | 131,700 | 171,500 | 190,700 |
| Income Tax | 32,400 | 21,900 | 16,400 | 34,500 | 29,400 |
| Net Income Continuous | 136,000 | 111,300 | 115,300 | 137,000 | 161,300 |
| Net Income | $136,000 | $111,300 | $115,300 | $137,000 | $161,300 |
| EPS Basic Total Ops | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 |
| EPS Basic Continuous Ops | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 |
| EPS Diluted Total Ops | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 |
| EPS Diluted Continuous Ops | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 |
| EPS Diluted Before Non-Recurring Items | 1.85 | 1.52 | 1.56 | 1.83 | 2.16 |
| EBITDA(a) | $201,500 | $165,100 | $158,400 | $196,800 | $213,000 |